QNASL (BECLOMETHASONE DIPROPIONATE) — FDA Approval NDA202813 (TEVA BRANDED PHARM)
QNASL (BECLOMETHASONE DIPROPIONATE) — FDA Approval NDA202813 (TEVA BRANDED PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: QNASL; Active ingredients: BECLOMETHASONE DIPROPIONATE; Application number: NDA202813.
| Brand name | QNASL |
|---|---|
| Active ingredients | BECLOMETHASONE DIPROPIONATE |
| Application number | NDA202813 |
| Sponsor | TEVA BRANDED PHARM |
| Dosage form | AEROSOL, METERED |
| Route | NASAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20120323 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →